Evidence map›Paper›PMID 40001603›Full record

ArticleBiomolecules2025

Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control Study.

Emilie Han, Katrin Müller-Zlabinger, Ena Hasimbegovic, Laura Poschenreithner, Nina Kastner, Babette Maleiner, Kevin Hamzaraj, Andreas Spannbauer, Martin Riesenhuber, Anja Vavrikova and 5 more

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Emilie HanDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3064-1277
Katrin Müller-ZlabingerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3855-7643
Ena HasimbegovicDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Laura PoschenreithnerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Nina KastnerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-1576-9029
Babette MaleinerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Kevin HamzarajDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-2505-8554
Andreas SpannbauerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9819-0361
Martin RiesenhuberDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5061-7354
Anja VavrikovaDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Antonia DomanigDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
Christian NitscheDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-0141-7639
Dominika LukovicDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-8040-8086
Thomas A ZelnikerDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-6444-8598
Mariann GyöngyösiDivision of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7083-2107

Funding

FWF Austrian Science Fund KLI 1064-BMedical Scientific Fund of the Mayor of the City of Vienna 21176
6 · The paper itself

Abstract

Endothelial dysfunction mediated by elevated levels of autoantibodies against vasoactive peptides occurring after COVID-19 infection is proposed as a possible pathomechanism for orthostatic intolerance in long COVID patients. This case-control study comprised 100 long COVID patients from our prospective POSTCOV registry and three control groups, each consisting of 20 individuals (Asymptomatic post-COVID group; Healthy group = pan-negative for antispike protein of SARS-CoV-2; Vaccinated healthy group = no history of COVID-19 and vaccinated). Autoantibodies towards muscarinic acetylcholine receptor M3, endothelin type A receptor (ETAR), beta-2 adrenergic receptor (Beta-2 AR), angiotensin II receptor 1 and angiotensin 1-7 (Ang1-7) concentrations were measured by enzyme-linked immunosorbent assay in long COVID patients and controls. Orthostatic intolerance was defined as inappropriate sinus tachycardia, postural tachycardia, orthostatic hypotonia and other dysautonomia symptoms, such as dizziness or blurred vision (

Indexed as

AutoantibodiesCOVID-19Orthostatic IntoleranceAdultAgedBiomarkersCase-Control StudiesFemaleHumansMaleMiddle AgedProspective StudiesReceptor, Endothelin AReceptors, Adrenergic, beta-2SARS-CoV-2AutoantibodiesBiomarkersReceptor, Endothelin AReceptors, Adrenergic, beta-2autoantibodiesendothelial dysfunctionlong COVIDorthostatic intolerancepost COVIDvasoactive peptides

Identifiers

PMID40001603
PMCPMC11853648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.